IBM Watson Health

By  MobiHealthNews 02:59 pm February 15, 2021
SPAC rumors pan out. Just a few weeks after rumors spread of Sharecare's upcoming merger with a special purpose acquisition company (SPAC), the patient-engagement and benefits-navigation platform made it official with an announcement on Friday. Sharecare will be merging with Falcon Capital Acquisition and listing on NASDAQ. The deal is set to be funded through $345 million in cash in trust from...
By  Dave Muoio 04:01 pm January 17, 2019
Dr. Bimal Shah and Courtnee Westendorf have been announced as the chief medical officer and chief marketing officer, respectively, of Livongo Health. Shah was promoted internally from a position of SVP of clinical strategy, while Westendorf previously served as the chief marketing officer of the Oakland Raiders football team. “We are excited to have a leading marketing executive like Courtnee...
By  Dave Muoio 12:26 pm January 3, 2019
Sugar.IQ — the digital diabetes assistant for Guardian Connect system users that is jointly supported by Medtronic and IBM Watson — has a new feature that uses artificial intelligence to predict future low glucose events. Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These...
By  Jonah Comstock 02:41 pm October 22, 2018
Deborah DiSanzo has stepped down as the head of IBM Watson Health, STAT News reports. Official details around the reasons for the move are scarce, but STAT notes that the division has had some issues of late, including outside criticisms of the program's effectiveness and problems integrating the recent acquisitions.  DiSanzo will move to the strategy team at IBM Cognitive Solutions. John Kelly,...
By  Dave Muoio 06:03 am July 19, 2018
The Department of Veterans Affairs and IBM Watson Health have announced a one-year extension to an ongoing public-private partnership applying the AI company’s technology to genomic data for cancer therapy. The precision oncology collaboration has so far assisted the treatment of more than 2,700 veterans, according to a statement, although the original agreement in 2016 had proposed the lofty...
By  Jonah Comstock 04:06 pm May 4, 2018
Worries about artificial intelligence replacing doctors — at least any time soon — have largely given way to a vision of doctors and algorithms working together to give patients the best possible treatment. But what exact shape that collaboration will take is still being hammered out by developers and doctors. At Health 2.0’s Dev4Health conference, held this week at the HIMSS Innovation Center in...
By  Heather Mack 05:01 pm June 8, 2017
Novartis and IBM Watson are working together on a new initiative to improve cancer care. In what the pharmaceutical company called a “first-of-its-kind collaboration, the two will use IBM Watson’s cognitive computing tools to leverage Novartis’s portfolio of breast cancer compounds and real-world patient data. The goal is to use data analytics and machine learning to determine which combinations...
By  Heather Mack 11:31 am March 31, 2017
In the first quarter of 2017, we tracked seven digital health-related FDA clearances. While the list isn’t long, it’s varied and relatively novel – from app and device integrations for diabetes treatment to a vest that maps cardiac rhythms. The beginning of this year also rang in some big changes, as the Trump Administration took root and nominated Dr. Scott Gottlieb as FDA deputy commissioner....
By  Heather Mack 12:31 pm February 21, 2017
Austin-based EverlyWell has added a new kit to its at-home testing service: now, women who are nursing have the ability to test the DHA levels in their breast milk. “There is tons of research supporting the benefits of DHA levels in breast milk and how that correlates to the baby’s development and inflammatory responses like respiratory allergies, asthma and exzema, so the more DHA you can...
By  Heather Mack 02:42 am January 11, 2017
IBM Watson Health has announced a joint initiative with the US Food and Drug Administration to study the use of blockchain technology to share health data to ultimately improve public health. At first, the two-year collaboration will focus on oncology data, pulling together and exchanging data from a variety of sources including that from clinical trials, genomic data, EMRs, and from...